CD36 and metabolic dysfunction-associated steatohepatitis: Moreover, our previous work has demonstrated that CD36 plays an important role in balancing hepatic ROS and regulating macrophage infiltration, which could be a new potential therapeutic strategy to prevent NASH development [29].